Clinical trial of intravitreal injections of dexamethasone vs bevacizumab in diabetic foveal oedema resistant to laser [ 2010 - 2012 ]

Research Grant

Researchers: Prof Mark Gillies (Principal investigator) ,  A/Pr Samantha Fraser-Bell ,  Dr Andrew Kaines

Brief description Diabetic macular oedema (swelling in the back of the eye) occurs in 20% of patients who have had diabetes for 10 years, and causes progressive vision loss. This project aims to determine whether there may be a difference between treatment with bevaciumab -VEGF inhibitor- and steroids used as eye injections inpatients with diabetic macular oedema losing vision despite standard laser treatment.

Funding Amount $AUD 336,398.24

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant